Thromb Haemost 1988; 59(03): 396-399
DOI: 10.1055/s-0038-1647503
Original Article
Schattauer GmbH Stuttgart

HIV-Antibody Seroconversions in Dutch Haemophiliacs Using Heat-Treated and Non Heat-Treated Coagulation Factor Concentrates

Authors

  • Tom F W Wolfs

    The Human Retrovirus Laboratory of the Department of Virology and the Pediatric Department, The Netherlands
  • Cees Breederveld

    *   The Division of Hemostasis and Thrombosis, Academic Medical Centre of the University of Amsterdam, The Netherlands
  • Willy J A Krone

    The Human Retrovirus Laboratory of the Department of Virology and the Pediatric Department, The Netherlands
  • Lia v d Hoek

    The Human Retrovirus Laboratory of the Department of Virology and the Pediatric Department, The Netherlands
  • Margreet Bakker

    The Human Retrovirus Laboratory of the Department of Virology and the Pediatric Department, The Netherlands
  • Lia Smit

    The Human Retrovirus Laboratory of the Department of Virology and the Pediatric Department, The Netherlands
  • Jaap Goudsmit

    The Human Retrovirus Laboratory of the Department of Virology and the Pediatric Department, The Netherlands
  • The Dutch haemophilia group
Further Information

Publication History

Received 28 July 1986

Accepted after revision 19 January 1988

Publication Date:
26 July 2018 (online)

Preview

Summary

A national multicentre study was performed to investigate the effects of donorselection and the use of heat-treated plasma products on seroconversion to HIV in 157 Dutch haemophiliacs. All patients included in the study were seronegative for HIV antibodies in 1983.

Thirteen percent (20/157) seroconverted between 1983 and 1986. Nineteen of 20 seroconversions could be related to the use of non heat-treated products in the year preceding HIV antibody seroconversion. One seroconversion occurred in a person using heat-treated non donor screened product.

Seroconversion rate decreased as a result of the policy to discourage high risk blood donors and no seroconversions were observed following the introduction of donor screening in 1985.